{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:43:11Z","timestamp":1792856591668,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.oret.2018.03.001","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T20:07:12Z","timestamp":1523995632000},"page":"1028-1040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["A Randomized Phase 2 Study of an Anti\u2013Amyloid \u03b2 Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration"],"prefix":"10.1016","volume":"2","author":[{"given":"Philip J.","family":"Rosenfeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Reichel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Danis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angie","family":"Gress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindy","family":"Magee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura R.","family":"Parham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2018.03.001_bib1","first-page":"1","article-title":"The pathophysiology of geographic atrophy secondary to age-related macular degeneration and the complement pathway as a therapeutic target","volume":"0","author":"Boyer","year":"2016","journal-title":"Retina"},{"key":"10.1016\/j.oret.2018.03.001_bib2","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ng.3448","article-title":"A\u00a0large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants","volume":"48","author":"Fritsche","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.oret.2018.03.001_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ophtha.2006.09.016","article-title":"The long-term natural history of geographic atrophy from age-related macular degeneration: enlargement of atrophy and implications for interventional clinical trials","volume":"114","author":"Sunness","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.03.001_bib4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2006.11.041","article-title":"Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration","volume":"143","author":"Holz","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.oret.2018.03.001_bib6","doi-asserted-by":"crossref","first-page":"eaaf1443","DOI":"10.1126\/scitranslmed.aaf1443","article-title":"Targeting factor D of the alternative complement pathway reduces geographic atrophy progression secondary to age-related macular degeneration","volume":"9","author":"Yaspan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.oret.2018.03.001_bib7","author":"Roche"},{"key":"10.1016\/j.oret.2018.03.001_bib9","first-page":"2234","article-title":"A common SNP at the CFI locus is associated with rapid progression of geographic atrophy","volume":"55","author":"Yaspan","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.03.001_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.exer.2003.10.011","article-title":"Characterization of \u03b2 amyloid assemblies in drusen: the deposits associated with aging and age-related macular degeneration","volume":"78","author":"Anderson","year":"2004","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.oret.2018.03.001_bib11","first-page":"4294","article-title":"Are systemic levels of amyloid \u00df altered in patients with geographic atrophy?","volume":"57","author":"Lashkari","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.03.001_bib12","first-page":"12","article-title":"Complement factor I bioactivity: a potential biomarker for anti-amyloid beta treatment in age-related macular degeneration\/geographic atrophy","volume":"57","author":"Lopez","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.03.001_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jcp.21742","article-title":"Amyloid-beta up-regulates complement factor b in retinal pigment epithelial cells through cytokines released from recruited macrophages\/microglia: another mechanism of complement activation in age-related macular degeneration","volume":"220","author":"Wang","year":"2009","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.oret.2018.03.001_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0065518","article-title":"Systemic administration of Abeta mAb reduces retinal deposition of Abeta and activated complement C3 in age-related macular degeneration mouse model","volume":"8","author":"Catchpole","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2018.03.001_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.visres.2007.07.025","article-title":"Targeting age-related macular degeneration with Alzheimer\u2019s disease based immunotherapies: anti-amyloid-\u03b2 antibody attenuates pathologies in an age-related macular degeneration mouse model","volume":"48","author":"Ding","year":"2008","journal-title":"Vis Res"},{"key":"10.1016\/j.oret.2018.03.001_bib16","doi-asserted-by":"crossref","first-page":"E279","DOI":"10.1073\/pnas.1100901108","article-title":"Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration","volume":"108","author":"Ding","year":"2011","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.oret.2018.03.001_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098153","article-title":"First administration of the Fc-attenuated anti-\u03b2 amyloid antibody GSK933776 to patients with mild Alzheimer\u2019s disease: a randomized, placebo-controlled study","volume":"10","author":"Andreasen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.oret.2018.03.001_bib18","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE Study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.03.001_bib19","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrg2344","article-title":"Genome-wide association studies for complex traits: consensus, uncertainty and challenges","volume":"9","author":"McCarthy","year":"2008","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.oret.2018.03.001_bib20","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/gepi.20297","article-title":"Estimation of significant thresholds for genomewide association scans","volume":"32","author":"Dudbridge","year":"2008","journal-title":"Genet Epidemiol"},{"key":"10.1016\/j.oret.2018.03.001_bib21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/ng1847","article-title":"Principal components analysis corrects for stratification in genome-wide association studies","volume":"38","author":"Price","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.oret.2018.03.001_bib22","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.oret.2018.03.001_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","article-title":"Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography","volume":"118","author":"Yehoshua","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.03.001_bib24","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ophtha.2016.01.034","article-title":"Anatomic clinical trial endpoints for nonexudative age-related macular degeneration","volume":"123","author":"Schall","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oret.2018.03.001_bib25","doi-asserted-by":"crossref","first-page":"984041","DOI":"10.1155\/2013\/984041","article-title":"Disease modifying therapies for Alzheimer\u2019s disease targeting A\u03b2 oligomers: implications for therapeutic mechanisms","volume":"2013","author":"Matsubara","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.oret.2018.03.001_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bpc.2009.12.004","article-title":"Real-time observation of model membrane dynamics induced by Alzheimer\u2019s amyloid beta","volume":"147","author":"Morita","year":"2010","journal-title":"Biophys Chem"},{"key":"10.1016\/j.oret.2018.03.001_bib27","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1001\/archophthalmol.2009.198","article-title":"Change in area of geographic atrophy in the Age-Related Eye Disease Study","volume":"127","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2018.03.001_bib28","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-2011-101908","article-title":"Age-related macular degeneration (AMD): Alzheimer\u2019s disease in the eye?","volume":"24","author":"Kaarniranta","year":"2011","journal-title":"J\u00a0Alzheimers Dis"},{"key":"10.1016\/j.oret.2018.03.001_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1167\/iovs.12-10827","article-title":"The aging eye: common degenerative mechanisms between the Alzheimer\u2019s brain and retinal disease","volume":"54","author":"Sivak","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oret.2018.03.001_bib30","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.oret.2018.03.001_bib31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3928\/23258160-20150730-15","article-title":"Association between growth of geographic atrophy and the complement factor I locus","volume":"46","author":"Yehoshua","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.oret.2018.03.001_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126636","article-title":"Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration","volume":"10","author":"Grassman","year":"2015","journal-title":"PLoS One"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017307418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653017307418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:25:30Z","timestamp":1762853130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653017307418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2468653017307418"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2018.03.001","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Randomized Phase 2 Study of an Anti\u2013Amyloid \u03b2 Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2018.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}